No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
6220 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2569 |
4. Check minimum number of eventsNone |
2569 |
5. Include endpointsNone |
2569 |
6. Filter based on genotype QC (FinnGen only) |
2569 |
Control definitions (FinnGen only)
- Control exclude
- AUTOIMMUNE
- Control conditions
- not E4_THYTOXGOITDIF
Extra metadata
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Autoimmune hyperthyroidism
based on the number of shared cases.
Similar with more cases:
- Thyrotoxicosis with diffuse goitre
- Thyrotoxicosis, other and/or unspecified
- Thyrotoxicosis
- Disorders of thyroid, IBD co-morbidities
- Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 14824 | 11965 | 2766 |
| Only index persons | 14358 | 11690 | 2668 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.29 | 0.34 | 0.08 |
| Only index persons | 0.37 | 0.43 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 50.67 | 50.39 | 52.43 |
| Only index persons | 50.46 | 50.13 | 51.92 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2569 | 2134 | 435 |
| Unadjusted period prevalence (%) | 0.64 | 0.73 | 0.19 |
| Median age at first event (years) | 50.53 | 49.43 | 55.93 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2279
- Matched controls
- 22789
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
323.0
587
*
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
43.5
323.0
409
114
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
216.6
323.0
349
19
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
31.2
323.0
446
176
104
Kela drug reimbursment
Thyroid insufficiency
40.8
323.0
671
231
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
4503599627370496.0
323.0
2263
5
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
1169.8
323.0
2018
152
BAA60
NOMESCO Finland
Total thyroidectomy
34.8
323.0
601
232
H03AA01
ATC
levothyroxine sodium; systemic
92.3
323.0
1708
715
H03BB01
ATC
carbimazole; oral
993.6
323.0
2006
171
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
106.2
287.8
312
34
C07AA05
ATC
propranolol; systemic
5.9
286.8
1023
2757
H062, E050
ICD-10 Finland
NA
+∞
187.1
177
*
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
974.9
186.2
180
*
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
30.3
169.5
230
84
E03
ICD-10 Finland
Other hypothyroidism
22.0
141.7
211
105
T86
ICPC
Hypothyroidism/myxoedema
26.5
135.1
190
78
C07AB07
ATC
bisoprolol; oral
3.0
132.7
1182
5980
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.2
132.5
955
4173
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.9
124.7
1193
6239
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
40.7
123.6
156
41
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
33.4
122.7
162
52
E03.89
ICD-10 Finland
Other specified hypothyroidism
33.9
122.3
161
51
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
19.1
119.9
187
106
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
156.8
113.3
119
8
T85
ICPC
Hyperthyroidism/thyrotoxicosis
68.3
106.9
123
19
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.4
100.8
285
499
H02AB06
ATC
prednisolone; systemic
2.5
90.6
1125
6411
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
66.7
83.2
96
15
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
8.1
81.2
191
254
H05.2
ICD-10 Finland
Exophthalmic conditions
80.8
69.5
78
10
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
88.6
69.4
77
9
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
73.2
68.6
78
11
E05.89
ICD-10 Finland
Other thyrotoxicosis
78.7
67.5
76
10
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
635.2
63.1
62
*
H53.2
ICD-10 Finland
Diplopia
7.6
59.4
145
203
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
26.5
58.9
82
32
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
94.1
58.2
64
7
H03BA02
ATC
propylthiouracil; oral
299.3
57.5
58
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
54.4
52
*
K90.0
ICD-10 Finland
Coeliac disease
20.2
53.0
80
41
H02AB07
ATC
prednisone; oral
2.9
52.1
349
1322
H50.2
ICD-10 Finland
Vertical strabismus
17.8
50.0
79
46
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.2
48.7
286
988
A10AA01
ATC
NA
79.1
48.1
54
7
H04AA01
ATC
glucagon; nasal, parenteral
57.3
47.7
56
10
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
245.0
47.2
48
*
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
+∞
47.0
45
*
T89
ICPC
Diabetes insulin dependent
16.3
46.7
76
48
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
23.0
46.3
67
30
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
46.0
394
1719
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
22.2
45.9
67
31
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
60.2
45.5
53
9
E05.5
ICD-10 Finland
Thyroid crisis or storm
+∞
44.9
43
*
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
14.7
43.6
74
52
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
42.8
849
5372
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.5
41.2
153
358
K51.5
ICD-10 Finland
Left sided colitis
+∞
40.7
39
*
H04.10
ICD-10 Finland
Dry eye syndrome
2.9
40.6
277
1052
XCK00
NOMESCO Finland
Perimetry
3.5
40.4
202
616
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
39.8
459
2316
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
+∞
39.7
38
*
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
36.5
39.2
50
14
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
7.6
38.8
93
127
ZX120
NOMESCO Finland
Intravenous
3.1
38.7
234
817
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
+∞
37.6
36
*
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
14.8
36.8
62
43
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.6
35.4
128
292
E06.3
ICD-10 Finland
Autoimmune thyroiditis
59.6
35.2
41
7
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.5
34.5
127
295
ZXA10
NOMESCO Finland
Bilateral
2.1
34.1
433
2262
A11CC03
ATC
alfacalcidol; systemic
8.4
34.0
76
93
A10AA02
ATC
NA
15.1
33.6
56
38
CA1AD
NOMESCO Finland
Orbita CT
56.6
33.3
39
7
E10
ICD-10 Finland
Type 1 diabetes mellitus
49.5
32.6
39
8
CAC44
NOMESCO Finland
Combined decompression of orbit
+∞
32.4
31
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
22.9
31.4
45
20
107
Kela drug reimbursment
Pernicious anaemia
+∞
31.3
30
*
P01BA02
ATC
hydroxychloroquine; oral
4.1
31.1
125
316
XCD10
NOMESCO Finland
Electrophysiological examination of eye
5.8
29.5
86
154
A02BC02
ATC
pantoprazole; systemic
1.7
29.3
1378
10933
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
6.9
29.3
74
110
G35
ICD-10 Finland
Multiple sclerosis
146.8
27.7
29
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
27.4
584
3666
CBK00
NOMESCO Finland
Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction
+∞
27.1
26
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
38.3
27.1
34
9
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
32.3
26.9
35
11
H50.6
ICD-10 Finland
Mechanical strabismus
274.1
26.8
27
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
26.4
507
3067
C07AB02
ATC
metoprolol; systemic
2.0
26.4
403
2245
A07EC02
ATC
mesalazine; oral, rectal
6.0
26.4
74
127
A07EC01
ATC
sulfasalazine; oral, rectal
4.1
26.3
105
264
A10AE05
ATC
insulin detemir; parenteral
4.5
25.9
94
216
XCK10
NOMESCO Finland
Photography of fundus of eye
2.6
25.8
197
792
2AB04
NOMESCO Finland
NA
94.5
25.7
28
*
H50.8
ICD-10 Finland
Other specified strabismus
50.6
25.3
30
6
CAC20
NOMESCO Finland
Lateral decompression of orbit
+∞
25.0
24
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
19.8
24.8
37
19
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
10.2
24.8
49
49
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.0
24.7
344
1848
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
24.4
536
3378
H3600, E103
ICD-10 Finland
NA
+∞
24.0
23
*
A10AE04
ATC
insulin glargine; parenteral
3.1
23.8
136
456
CEC00
NOMESCO Finland
Recession of extraocular muscle
17.1
23.6
37
22
L04AA13
ATC
leflunomide; oral
17.1
23.6
37
22
109
Kela drug reimbursment
Multiple sclerosis
+∞
22.9
22
*
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
+∞
22.9
22
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
52.5
22.1
26
5
H02.5
ICD-10 Finland
Other disorders affecting eyelid function
35.4
22.1
28
8
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
21.9
21
*
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
+∞
21.9
21
*
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
222.0
21.6
22
*
C03CA01
ATC
furosemide; systemic
1.8
21.4
425
2577
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
34.1
21.1
27
8
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
+∞
20.9
20
*
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
+∞
20.9
20
*
106
Kela drug reimbursment
Hypoparathyroidism
19.6
20.8
31
16
L04AX01
ATC
azathioprine; systemic
7.9
20.3
46
59
C01BD01
ATC
amiodarone; systemic
4.8
20.1
68
146
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.3
19.9
103
323
L40.0
ICD-10 Finland
Psoriasis vulgaris
9.3
19.8
41
45
R00.0
ICD-10 Finland
Tachycardia, unspecified
3.1
19.6
109
360
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
105.9
19.6
21
*
WF099
NOMESCO Finland
Other radiotherapy
12.2
19.6
35
29
H50.0
ICD-10 Finland
Convergent concomitant strabismus
9.0
18.6
39
44
H02AB09
ATC
hydrocortisone; systemic
5.4
18.5
55
103
B03BA03
ATC
hydroxocobalamin; parenteral
3.6
18.4
83
234
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.0
18.4
106
359
N02BE01
ATC
paracetamol; systemic, rectal
1.6
18.1
1863
16741
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
18.1
413
2606
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.0
18.1
104
352
K51.8
ICD-10 Finland
Other ulcerative colitis
52.9
18.0
21
*
E83.51
ICD-10 Finland
Hypocalcemia
16.7
17.8
28
17
TFP20
NOMESCO Finland
Cardiodefibrillation
2.7
17.8
128
498
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
+∞
17.7
17
*
H3601, E103
ICD-10 Finland
NA
+∞
17.7
17
*
H3603, E103
ICD-10 Finland
NA
+∞
17.7
17
*
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
8.7
17.4
37
43
R00.2
ICD-10 Finland
Palpitations
2.2
17.3
180
851
R53
ICD-10 Finland
Malaise and fatigue
1.7
16.9
405
2583
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
63.8
16.7
19
*
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
6.6
16.4
42
65
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
16.2
803
6118
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.9
16.0
99
353
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
16.0
344
2126
N05CF01
ATC
zopiclone; oral
1.5
15.8
608
4371
WX110
NOMESCO Finland
Local anesthesy
1.4
15.5
1476
12746
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
161.0
15.5
16
*
A10AE06
ATC
insulin degludec; parenteral
5.8
15.4
43
75
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
12.4
15.3
27
22
B01AA03
ATC
warfarin; systemic
1.8
15.3
287
1696
CEC60
NOMESCO Finland
Transposition of extraocular muscle with adjustable suture
45.3
15.1
18
*
R06.0
ICD-10 Finland
Dyspnoea
1.6
14.9
436
2930
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
31.9
14.8
19
6
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
21.2
14.6
21
10
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.4
14.6
123
525
L88
ICPC
Rheumatoid/seropositive arthritis
4.7
14.6
49
106
E05.3
ICD-10 Finland
Thyrotoxicosis from ectopic thyroid tissue
+∞
14.6
14
*
G73.0*E05.9
ICD-10 Finland
Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]
+∞
14.6
14
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
14.4
272
1611
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
14.3
165
813
J01DB01
ATC
cefalexin; oral
1.5
14.3
1746
15688
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
14.2
583
4239
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.1
14.1
160
784
A02BC05
ATC
esomeprazole; systemic
1.4
14.0
805
6271
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
53.7
13.8
16
*
CEW99
NOMESCO Finland
Other operation on extraocular muscle
20.2
13.8
20
10
177
Kela drug reimbursment
Insulin glargine 300 U / ml
7.6
13.6
31
41
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.4
13.6
116
498
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
75.6
13.6
15
*
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
75.6
13.6
15
*
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
14.8
13.6
22
15
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
+∞
13.6
13
*
K50.8
ICD-10 Finland
Other Crohn disease
+∞
13.6
13
*
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
+∞
13.6
13
*
E05.4
ICD-10 Finland
Thyrotoxicosis factitia
34.2
13.5
17
5
M01CB01
ATC
sodium aurothiomalate; parenteral
34.2
13.5
17
5
K50.0
ICD-10 Finland
Crohn disease of small intestine
140.8
13.5
14
*
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
25.9
13.4
18
7
H02AB04
ATC
methylprednisolone; systemic
1.7
13.1
267
1619
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
13.1
725
5588
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.8
13.0
238
1395
C07AA07
ATC
sotalol; systemic
3.2
12.9
68
219
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
12.7
269
1648
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.0
12.7
74
255
207
Kela drug reimbursment
Chronic arrhythmias
1.8
12.7
212
1204
WX402
NOMESCO Finland
General anaesthesia
1.6
12.7
347
2286
N02AX02
ATC
tramadol; systemic, rectal
1.4
12.6
762
5958
K50.9
ICD-10 Finland
Crohn disease, unspecified
70.2
12.6
14
*
K50.1
ICD-10 Finland
Crohn disease of large intestine
70.2
12.6
14
*
CA1BD
NOMESCO Finland
Extensive orbita CT
70.2
12.6
14
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
12.5
12
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
130.7
12.4
13
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.7
12.4
283
1772
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
12.2
190
1052
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
6.4
12.1
31
49
K04
ICPC
Palpitations/awareness of heart
2.3
12.0
114
517
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
6.6
12.0
30
46
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
21.4
12.0
17
8
A07EA02
ATC
hydrocortisone; rectal
7.3
12.0
28
39
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
11.9
1144
9670
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
30.2
11.6
15
5
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
6.9
11.6
28
41
353
Kela drug reimbursment
Cladribine and fingolimod
+∞
11.5
11
*
164
Kela drug reimbursment
Fingolimod
+∞
11.5
11
*
A11CC02
ATC
dihydrotachysterol; oral
13.7
11.4
19
14
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
120.6
11.4
12
*
B01AB05
ATC
enoxaparin; parenteral
1.4
11.2
541
4037
A02BC01
ATC
omeprazole; systemic
1.5
11.2
494
3624
XF404
NOMESCO Finland
Ambulatory ECG
1.9
10.9
160
869
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
10.9
468
3410
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
10.8
474
3466
TFP34
NOMESCO Finland
Electrophysiological investigation
2.9
10.7
64
226
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
10.7
448
3246
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
10.7
320
2149
SPAT1262
SPAT
Handing over of treatment supplies
1.6
10.5
265
1702
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
10.4
329
2237
C01AA05
ATC
digoxin; systemic
2.3
10.4
95
423
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
110.5
10.4
11
*
E50.0
ICD-10 Finland
Vitamin A deficiency with conjunctival xerosis
110.5
10.4
11
*
M14.5*E05.9
ICD-10 Finland
Arthropathy in thyrotoxicosis [hyperthyroidism]
110.5
10.4
11
*
L03AX13
ATC
glatiramer acetate; parenteral
+∞
10.4
10
*
L04AA27
ATC
fingolimod; oral
+∞
10.4
10
*
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
+∞
10.4
10
*
A12AA04
ATC
calcium carbonate; oral
5.9
10.4
28
48
B81
ICPC
Anaemia vit B12/folate deficiency
3.4
10.2
48
144
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.7
10.1
199
1193
L01BB02
ATC
mercaptopurine; oral
14.6
10.0
16
11
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
3.8
10.0
41
110
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
40.2
10.0
12
*
L13.0
ICD-10 Finland
Dermatitis herpetiformis
40.2
10.0
12
*
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
40.2
10.0
12
*
E06.4
ICD-10 Finland
Drug-induced thyroiditis
40.2
10.0
12
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
10.0
127
656
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
26.1
9.8
13
5
UJF32
NOMESCO Finland
Coloscopy
1.5
9.8
397
2852
R01AD08
ATC
fluticasone; nasal
1.4
9.6
577
4469
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
9.5
264
1740
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
9.5
274
1822
R63.4
ICD-10 Finland
Abnormal weight loss
2.8
9.4
60
221
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
+∞
9.4
9
*
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
9.4
190
1150
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
9.3
201
1239
WX002
NOMESCO Finland
Sedation and analgesia
1.5
9.3
330
2304
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
9.2
565
4384
I47.1
ICD-10 Finland
Supraventricular tachycardia
2.3
9.2
84
374
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
9.2
222
1411
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
9.1
134
729
SGA01
NOMESCO Finland
Tooth opening as first aid
1.5
9.1
319
2220
H01.0
ICD-10 Finland
Blepharitis
2.0
9.0
110
560
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
4.7
9.0
29
62
J01AA02
ATC
doxycycline; systemic
1.3
9.0
1615
14703
A07EA06
ATC
budesonide; oral, local oral
3.7
9.0
37
100
N86
ICPC
Multiple sclerosis
18.7
8.9
13
7
R50.9
ICD-10 Finland
Fever, unspecified
1.6
8.9
227
1461
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
3.7
8.9
37
101
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
24.1
8.9
12
5
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
5.8
8.9
24
42
XCH00
NOMESCO Finland
Eye pressure measurement
2.4
8.9
71
298
CE2W4
NOMESCO Finland
Eye movement mapping
12.6
8.9
15
12
N06AX21
ATC
duloxetine; oral
1.7
8.9
200
1249
A04
ICPC
Weakness/tiredness general
1.6
8.9
234
1521
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.8
8.8
143
810
H57.1
ICD-10 Finland
Ocular pain
2.5
8.7
67
276
R03AC02
ATC
salbutamol; inhalant
1.3
8.7
1057
9081
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
8.7
285
1952
E06.1
ICD-10 Finland
Subacute thyroiditis
4.9
8.7
27
56
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
8.7
571
4476
C08CA01
ATC
amlodipine; oral
1.4
8.7
524
4052
1XC02
NOMESCO Finland
NA
6.6
8.6
21
32
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.1
8.6
93
451
WX892
NOMESCO Finland
Monitored bed care
2.0
8.6
110
569
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
8.6
236
1552
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
8.6
143
814
M54.5
ICD-10 Finland
Low back pain
1.3
8.6
636
5081
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
8.6
184
1132
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
3.1
8.5
45
148
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
9.0
8.5
17
19
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
8.4
347
2500
L03AB07
ATC
interferon beta-1a; parenteral
+∞
8.3
8
*
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
+∞
8.3
8
*
M14.5*E03.9
ICD-10 Finland
Arthropathy in hypothyroidism (E00-E03+)
+∞
8.3
8
*
L04AA31
ATC
teriflunomide; oral
+∞
8.3
8
*
105
Kela drug reimbursment
Adrenal cortical hypofunction
+∞
8.3
8
*
G70.0
ICD-10 Finland
Myasthenia gravis
+∞
8.3
8
*
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
+∞
8.3
8
*
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
8.3
164
986
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
8.3
148
864
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
8.2
880
7413
SPAT1263
SPAT
Sampling
1.3
8.2
804
6686
M25.5
ICD-10 Finland
Pain in joint
1.4
8.1
543
4258
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
8.1
208
1341
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
8.1
910
7712
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
8.0
323
2310
A10AB06
ATC
insulin glulisine; parenteral
8.9
8.0
16
18
L40.5
ICD-10 Finland
Arthropathic psoriasis
22.1
8.0
11
5
R02
ICPC
Shortness of breath/dyspnoea
1.6
8.0
201
1293
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
8.0
1477
13362
F29
ICPC
Eye symptom/complaint other
1.7
8.0
148
872
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
2.7
7.9
51
192
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.8
749
6203
K80
ICPC
Cardiac arrhythmia NOS
1.8
7.7
132
757
C01BC04
ATC
flecainide; systemic
2.3
7.7
66
287
A10AA03
ATC
NA
15.1
7.7
12
8
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
7.7
313
2245
L04AB04
ATC
adalimumab; parenteral
7.4
7.7
17
23
K29.4
ICD-10 Finland
Chronic atrophic gastritis
3.8
7.6
30
79
CKC12
NOMESCO Finland
Photocoagulation of retina
2.3
7.6
66
290
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
7.6
665
5430
L28
ICPC
Limited function/disability (L)
1.5
7.6
226
1514
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
7.5
102
541
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
7.5
337
2465
N05BA04
ATC
oxazepam; oral
1.4
7.4
468
3634
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
80.3
7.4
8
*
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
80.3
7.4
8
*
J01MA02
ATC
ciprofloxacin; systemic
1.3
7.4
647
5276
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.8
7.4
122
695
AA1AD
NOMESCO Finland
CT of head and brain
1.4
7.4
354
2620
N03AX16
ATC
pregabalin; oral
1.4
7.4
396
2989
J01FF01
ATC
clindamycin; systemic
1.4
7.3
463
3592
E50.9
ICD-10 Finland
Vitamin A deficiency, unspecified
+∞
7.3
7
*
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
+∞
7.3
7
*
108
Kela drug reimbursment
Myasthenia gravis
+∞
7.3
7
*
L04AA24
ATC
abatacept; parenteral
+∞
7.3
7
*
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
+∞
7.3
7
*
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
10.9
7.3
13
12
A02BC03
ATC
lansoprazole; oral
1.3
7.3
496
3895
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
7.3
689
5682
H05.0
ICD-10 Finland
Acute inflammation of orbit
15.8
7.2
11
7
W84
ICPC
Pregnancy high risk
2.2
7.2
71
333
R4110
NOMESCO Finland
Physiotherapy
1.4
7.2
463
3603
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
7.2
574
4616
J01FA06
ATC
roxithromycin; oral
1.3
7.2
788
6625
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
7.2
141
849
K51
ICD-10 Finland
Ulcerative colitis
30.1
7.1
9
*
M01CB03
ATC
auranofin; oral
20.1
7.1
10
5
CS494
NOMESCO Finland
Other visual field testing
2.8
7.1
42
150
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
5.0
7.1
21
42
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
7.1
125
729
WX140
NOMESCO Finland
Parabulbar anesthesy
2.2
7.1
65
295
R51.80
ICD-10 Finland
Headache
1.5
7.0
282
2014
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
7.0
221
1502
A60
ICPC
General and Unspecified, Result test/procedure
2.1
7.0
77
380
R05
ICPC
Cough
1.4
6.9
405
3098
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
6.9
500
3962
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.9
294
2128
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
6.9
130
772
N02AA05
ATC
oxycodone; systemic
1.6
6.9
195
1290
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
6.9
413
3176
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
3.7
6.9
28
77
SPAT1097
SPAT
Recording of ECG
1.5
6.8
231
1592
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
3.4
6.8
31
93
ZXA00
NOMESCO Finland
Right side
1.4
6.8
444
3459
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
2.3
6.8
60
266
R94.6
ICD-10 Finland
Abnormal results of thyroid function studies
6.1
6.8
17
28
D69.0
ICD-10 Finland
Allergic purpura
40.2
6.8
8
*
E20.8
ICD-10 Finland
Other hypoparathyroidism
40.2
6.8
8
*
R03BA02
ATC
budesonide; inhalant
1.4
6.7
323
2391
R21
ICPC
Throat symptom/complaint
1.4
6.7
394
3019
J01FA10
ATC
azithromycin; systemic
1.3
6.7
1207
10764
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
4.1
6.7
24
59
N07AA02
ATC
pyridostigmine; systemic
22.6
6.7
9
*
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
22.6
6.7
9
*
R06AE07
ATC
cetirizine; oral
1.3
6.7
895
7703
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
2.0
6.7
85
443
I95.2
ICD-10 Finland
Hypotension due to drugs
7.8
6.6
14
18
E06.9
ICD-10 Finland
Thyroiditis, unspecified
5.9
6.6
17
29
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
5.5
6.6
18
33
J01MA12
ATC
levofloxacin; systemic
1.4
6.6
276
1992
L15
ICPC
Knee symptom/complaint
1.4
6.6
358
2706
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
6.5
73
360
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
6.5
258
1840
R07.0
ICD-10 Finland
Pain in throat
1.8
6.5
116
675
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
6.5
601
4926
L04AB01
ATC
etanercept; parenteral
6.9
6.5
15
22
N03AX12
ATC
gabapentin; oral
1.5
6.5
253
1800
L04AA01
ATC
[U] ciclosporin; systemic
5.3
6.5
18
34
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
70.0
6.4
7
*
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
70.0
6.4
7
*
S01XA18
ATC
ciclosporin; ophthalmic
7.4
6.4
14
19
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
14.3
6.4
10
7
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.9
6.4
91
496
R60.0
ICD-10 Finland
Localized oedema
1.6
6.4
162
1045
WZC30
NOMESCO Finland
Teaching
1.5
6.3
208
1425
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
6.3
174
1146
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
2.8
6.3
37
132
L40.8
ICD-10 Finland
Other psoriasis
11.0
6.3
11
10
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
6.3
116
687
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
18.1
6.3
9
5
RD210
NOMESCO Finland
NA
3.1
6.3
31
100
C09AA05
ATC
ramipril; oral
1.4
6.3
319
2383
G61.0
ICD-10 Finland
Guillain-Barré syndrome
+∞
6.3
6
*
H3602, E103
ICD-10 Finland
NA
+∞
6.3
6
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
+∞
6.3
6
*
24200
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi
+∞
6.3
6
*
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
+∞
6.3
6
*
Z96.4
ICD-10 Finland
Presence of endocrine implants
+∞
6.3
6
*
E06.5
ICD-10 Finland
Other chronic thyroiditis
+∞
6.3
6
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.7
6.2
38
140
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.2
1131
10057
D51.0
ICD-10 Finland
Vitamin B12deficiency anaemia due to intrinsic factor deficiency
26.7
6.2
8
*
M05BA04
ATC
alendronic acid; oral
1.7
6.2
115
679
AN1
HP
Coronary angiography
1.6
6.2
137
854
N07BA03
ATC
varenicline; oral
1.8
6.2
95
530
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.9
6.2
79
412
L17
ICPC
Foot/toe symptom/complaint
1.3
6.2
424
3328
SPAT1283
SPAT
Restricted health certificate
1.4
6.2
371
2853
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
4.5
6.2
20
45
R96
ICPC
Asthma
1.6
6.1
149
951
D07AD01
ATC
clobetasol; topical
1.4
6.1
246
1757
N06AX11
ATC
mirtazapine; oral
1.3
6.1
576
4724
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
6.1
105
607
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.0
6.1
76
393
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
1242
391
60.56
307.65
3.8
1.3
iu/l
5.9
2.6
9.45
840
98
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1336
1056
25.28
307.65
8.0
2.7
pmol/l
4.7
4.5
3.92
1256
948
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
659
1338
6.28
307.65
1.5
1.2
iu/ml
235.9
85.3
12.63
362
445
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2477
16522
14.94
238.58
15.0
2.9
pmol/l
15.7
14.3
127.47
2396
15157
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1566
9016
2.89
146.08
7.3
5.7
mmol/l
1.2
1.2
1.39
1344
7645
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1425
8099
2.71
131.37
6.5
5.0
mmol/l
1.2
1.2
0.18
1329
7310
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2499
19700
10.85
128.87
16.3
3.6
mu/l
1.7
2.1
1.77
2415
18216
(3013650) Neutrophils [#/volume] in Blood by Automated count
1729
11056
2.72
121.80
9.6
7.6
e9/l
3.8
4.0
4.19
1537
9516
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
405
1285
3.55
105.51
3.1
3.0
ng/l
63.4
79.7
2.87
375
1105
(3018418) pH of Serum or Plasma
1007
5275
2.50
103.39
5.3
3.5
ph
7.4
7.4
0.28
186
958
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1326
8045
2.34
95.50
2.6
2.0
nmol/l
76.0
77.0
0.70
1218
7280
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2018
15021
2.60
86.64
8.7
6.2
u/l
77.9
76.3
1.04
1935
14044
(3013115) Eosinophils [#/volume] in Blood
1457
9621
2.19
80.17
6.1
4.2
e9/l
0.2
0.2
0.33
1300
8371
(3006315) Basophils [#/volume] in Blood
1408
9238
2.16
77.92
5.8
4.0
e9/l
0.0
0.0
0.49
1228
7853
(3018010) Neutrophils/100 leukocytes in Blood
1369
8911
2.15
77.02
5.8
4.0
%
56.5
56.6
0.17
1288
8287
(3006504) Eosinophils/100 leukocytes in Blood
1342
8672
2.15
76.91
6.0
4.1
%
2.8
2.8
0.21
1254
8013
(42870588) Differential panel, method unspecified - Blood
1003
5789
2.20
76.87
5.7
4.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1400
9202
2.15
76.66
5.8
4.0
e9/l
0.6
0.6
0.03
1228
7830
(3002030) Lymphocytes/100 leukocytes in Blood
1382
9054
2.14
76.13
6.0
4.1
%
28.7
28.9
0.43
1293
8394
(3022096) Basophils/100 leukocytes in Blood
1302
8364
2.13
75.21
6.0
4.1
%
0.7
0.7
0.15
1217
7740
(3019198) Lymphocytes [#/volume] in Blood
1433
9552
2.13
75.02
5.8
4.1
e9/l
1.9
2.0
2.07
1285
8338
(3019069) Monocytes/100 leukocytes in Blood
1342
8733
2.12
74.77
6.2
4.3
%
8.4
8.2
2.92
1260
8137
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
69
59
11.99
68.02
1.6
1.7
pmol/l
15.8
13.6
1.92
61
51
(3015377) Calcium [Moles/volume] in Serum or Plasma
1078
6647
2.07
67.24
3.1
3.3
mmol/l
2.3
2.4
8.39
967
5875
(3013707) Erythrocyte sedimentation rate by Westergren method
1928
14987
2.15
60.10
4.4
3.0
mm/h
12.1
11.0
2.83
1811
13882
(40758558) Short blood count panel - Blood
832
4871
2.05
57.87
7.8
6.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
799
4662
2.04
55.71
1.4
1.2
u/ml
1.9
1.3
0.71
196
1257
(3036481) Cortisol [Moles/volume] in Serum or Plasma
366
1663
2.40
46.99
2.1
2.1
nmol/l
375.9
380.6
0.19
340
1522
(3013826) Glucose [Moles/volume] in Serum or Plasma
1490
11087
1.82
46.36
4.8
3.9
mmol/l
6.5
6.4
1.47
1403
10232
(3007164) IgA [Mass/volume] in Serum or Plasma
666
3867
1.98
45.59
1.5
1.4
g/l
2.1
2.2
0.94
398
2333
(3019550) Sodium [Moles/volume] in Serum or Plasma
2413
21467
3.04
42.68
16.9
12.2
mmol/l
139.7
139.8
0.43
2362
20883
(3023103) Potassium [Moles/volume] in Serum or Plasma
2416
21549
3.03
41.72
17.2
12.3
mmol/l
3.9
3.9
1.11
2364
20896
(3001019) Free T4 and TSH panel - Serum or Plasma
304
1344
2.43
41.22
2.2
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1095
7722
1.73
38.39
4.3
4.0
g/l
35.9
36.0
0.24
1018
7171
(3037522) Nuclear Ab [Titer] in Serum
445
2374
2.06
37.90
1.4
1.2
titre
508.1
353.5
1.37
104
367
(3021589) Normoblasts [#/volume] in Blood
1175
8509
1.70
36.92
10.8
7.3
e9/l
0.0
0.0
0.14
974
6785
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1046
7397
1.70
35.49
2.0
1.8
pmol/l
98.2
98.0
0.05
547
3604
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
83
184
4.63
34.88
3.6
5.6
u/ml
52.5
83.9
0.33
26
47
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
675
4276
1.78
33.59
2.4
2.0
mg/l
2.8
2.9
0.45
597
3630
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1243
9304
1.65
33.17
3.3
2.6
ug/l
102.4
96.3
0.42
1175
8726
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2247
19865
2.05
31.68
14.2
9.9
ml/min/173m2
85.6
84.1
2.72
1922
16077
(3012095) Magnesium [Moles/volume] in Serum or Plasma
478
2771
1.89
31.49
3.4
3.1
mmol/l
0.8
0.8
1.10
443
2581
(3003458) Phosphate [Moles/volume] in Serum or Plasma
383
2069
2.00
31.06
4.7
4.6
mmol/l
1.1
1.0
1.97
349
1913
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1296
9914
1.62
30.85
5.8
5.9
umol/l
10.7
10.7
0.06
1237
9372
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2350
21267
2.23
28.93
14.9
10.6
mg/l
19.2
22.5
5.50
1895
16219
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2462
22770
2.95
28.49
13.3
8.0
u/l
24.4
24.8
0.65
2418
21981
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
109
349
3.22
27.21
2.1
2.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
93
272
3.51
26.80
1.6
1.4
iu/ml
0.1
0.7
0.57
18
56
(3044889) 12 lead EKG panel
1698
14144
1.59
26.12
4.0
3.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2129
18874
1.75
24.51
5.9
4.7
mmol/mol
39.5
38.2
7.69
1993
17606
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
650
4390
1.64
24.34
3.2
2.7
ng/l
1273.1
1050.9
0.68
558
3700
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2437
22633
2.49
24.13
17.6
12.2
umol/l
71.1
70.7
0.29
2437
22621
(3044640) Blood type and Crossmatch panel - Blood
894
6528
1.57
24.09
2.2
2.1
—
—
—
0
0
(3019225) pH of Specimen
317
1743
1.93
24.09
4.5
3.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
543
3592
1.65
21.75
1.3
1.2
iu/ml
28.7
20.3
0.74
158
1030
(3005719) IgG [Mass/volume] in Serum or Plasma
218
1088
2.10
21.67
2.2
2.4
g/l
10.3
10.3
0.05
202
983
(3004789) Transferrin [Mass/volume] in Serum or Plasma
385
2334
1.76
21.25
2.5
2.1
g/l
2.4
2.4
0.51
355
2163
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
517
3400
1.65
21.12
1.3
1.2
u/ml
5.6
2.4
1.13
180
1370
(3032080) INR in Blood by Coagulation assay
917
6905
1.51
20.68
9.2
7.4
inr
1.2
1.2
1.13
285
2007
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
116
450
2.65
20.51
1.6
1.4
titre
285.7
95.0
—
7
16
(3022948) Iron [Moles/volume] in Serum or Plasma
411
2563
1.72
20.47
2.5
2.1
umol/l
13.7
13.8
0.06
374
2370
(3025159) Blasts/100 leukocytes in Blood
222
1149
2.02
19.97
3.3
3.7
%
0.0
0.4
0.63
46
268
(36660697) Celiac disease serology panel - Serum
298
1709
1.84
19.72
1.2
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
237
1264
1.96
19.57
3.3
3.6
%
0.9
0.9
0.09
51
342
(3021440) Promyelocytes/100 leukocytes in Blood
230
1214
1.98
19.57
3.3
3.7
%
0.1
0.3
1.03
50
319
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
899
6803
1.49
19.51
3.7
3.0
ng/l
44.2
37.6
0.19
542
3977
(40761511) CBC panel - Blood by Automated count
2417
22610
2.17
19.40
16.2
10.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
797
5901
1.51
19.16
2.6
2.3
u/l
54.1
57.6
2.54
743
5456
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
349
2117
1.75
19.10
2.6
2.1
%
22.6
23.2
0.34
296
1823
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
680
4873
1.54
19.03
2.1
2.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
365
2270
1.71
18.22
2.0
1.3
ug/g
135.1
82.5
1.16
294
1706
(3002179) Metamyelocytes/100 leukocytes in Blood
215
1142
1.96
17.94
3.1
3.5
%
0.6
0.7
0.13
38
251
(40760892) CBC W Ordered Manual Differential panel - Blood
598
4219
1.54
17.79
4.4
3.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
502
3404
1.59
17.78
3.9
3.2
ng/l
238.5
296.6
0.19
357
2320
(3002385) Erythrocyte distribution width [Ratio]
2009
17981
1.54
17.47
21.6
13.1
%
13.6
13.6
0.05
1981
17593
(3037467) Urinalysis macro (dipstick) panel - Urine
1630
13997
1.45
17.45
4.7
3.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
434
2865
1.62
17.13
1.7
1.7
nmol/l
1073.7
1161.7
1.45
353
2152
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
507
3497
1.56
16.56
2.8
2.8
mmol/l
2.4
2.4
0.83
428
3071
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1669
14460
1.44
16.55
3.2
2.7
u/l
41.8
40.6
0.21
1586
13603
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
249
1424
1.83
16.55
3.8
3.4
mmol/l
1.2
1.2
1.99
228
1230
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
859
6607
1.45
16.49
3.2
2.9
u/l
28.6
32.7
1.81
813
6307
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2239
20622
1.67
16.48
4.6
4.0
mmol/l
5.9
5.7
4.36
2089
19045
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
109
458
2.44
16.37
1.3
1.1
u/ml
127.4
10.7
—
6
20
(3013512) EKG study
706
5237
1.48
16.31
4.0
3.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
48
126
3.86
16.28
5.1
7.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1204
9862
1.42
16.25
3.7
3.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
168
855
2.03
15.81
1.8
1.8
g/l
1.3
1.4
0.79
155
771
(3026782) Osmolality of Urine
495
3440
1.54
15.53
3.0
2.4
mosm/kgh2o
510.6
537.8
2.04
418
2890
(3021960) Folate [Moles/volume] in Serum or Plasma
561
4019
1.51
15.24
1.5
1.5
nmol/l
19.9
20.6
0.59
489
3420
(3018095) Leukocytes [#/volume] in Urine
850
6610
1.43
15.05
3.9
3.1
e6/l
62.2
88.1
1.09
594
4387
(3033658) Prothrombin time (PT) actual/Normal
662
4927
1.46
14.80
4.1
3.3
%
92.2
94.8
1.79
646
4809
(3020961) Endomysium IgA Ab [Titer] in Serum
186
1009
1.91
14.57
1.1
1.1
titre
97.1
192.4
—
7
17
(3022217) INR in Platelet poor plasma by Coagulation assay
326
2092
1.64
14.27
23.6
20.5
inr
1.5
1.3
1.32
48
294
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
93
388
2.45
14.22
1.3
1.1
u/ml
38.6
2.3
—
6
21
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
102
446
2.34
14.05
1.7
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2513
24194
2.77
13.81
26.4
15.8
e9/l
262.3
259.8
1.26
2469
23560
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
88
363
2.47
13.79
1.2
1.1
u/ml
53.9
14.1
—
6
30
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
67
241
2.83
13.77
3.4
2.8
%
57.6
58.0
0.07
67
241
(3009508) Creatinine [Moles/volume] in Urine
682
5163
1.44
13.77
3.2
2.8
mmol/l
7.0
7.3
1.19
579
4336
(3002582) Erythrocytes [#/volume] in Urine
711
5426
1.43
13.72
3.5
2.7
e6/l
23.7
97.4
2.06
550
3971
(3024731) MCV [Entitic volume]
2514
24213
2.79
13.72
26.2
15.7
fl
90.6
90.6
0.04
2493
23884
(3035941) MCH [Entitic mass]
2514
24214
2.79
13.70
26.2
15.7
pg
30.1
30.2
0.73
2493
23885
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
93
395
2.41
13.68
1.3
1.1
u/ml
39.5
2.9
—
9
44
(3026361) Erythrocytes [#/volume] in Blood
2514
24218
2.78
13.61
26.3
15.8
e12/l
4.5
4.5
3.31
2463
23528
(3010813) Leukocytes [#/volume] in Blood
2514
24220
2.77
13.57
26.4
15.8
e9/l
6.6
6.6
0.22
2465
23516
(40768804) Tissue Pathology biopsy report
1102
9074
1.38
13.54
2.2
2.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
220
1287
1.78
13.52
3.0
2.7
ng/l
199.9
159.6
0.91
199
1159
(3000963) Hemoglobin [Mass/volume] in Blood
2514
24225
2.76
13.47
26.5
15.9
g/l
135.0
134.2
2.25
2495
23894
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
116
547
2.17
13.36
1.3
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1561
13604
1.38
13.35
4.8
4.0
e6/l
1958.2
2192.2
0.04
18
149
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
704
5391
1.42
13.25
2.2
1.9
u/l
246.1
208.9
0.13
661
5065
(3030467) Casts [#/volume] in Urine by Automated count
657
4971
1.43
13.21
3.4
2.6
e6/l
0.3
0.4
1.22
500
3589
(3017732) Neutrophils [#/volume] in Blood
220
1298
1.76
13.13
3.2
2.3
e9/l
3.9
4.0
0.27
183
1061
(3000850) Epithelial cells [#/volume] in Urine
504
3637
1.48
12.98
2.8
2.2
e6/l
6.4
7.4
0.81
437
3127
(3012516) Albumin [Mass/volume] in Urine
615
4619
1.44
12.82
3.4
2.8
mg/l
449.1
256.1
0.43
378
2717
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
619
4656
1.43
12.80
1.9
1.7
mg/l
0.9
1.0
0.35
444
3528
(3022145) Colonoscopy Study observation
297
1913
1.62
12.76
1.2
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
256
1590
1.68
12.68
2.6
2.2
%
1.7
1.8
0.56
233
1418
(3021788) Differential panel - Synovial fluid
63
230
2.78
12.63
1.7
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
642
4878
1.42
12.51
4.1
3.5
mg/mmol
7.5
7.7
0.05
381
2888
(3015171) Extractable nuclear Ab [Units/volume] in Serum
129
650
2.04
12.51
1.3
1.1
u/ml
0.3
1.0
—
10
59
(3017143) Hepatitis C virus Ab [Presence] in Serum
327
2185
1.57
12.02
1.5
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
108
517
2.14
12.00
2.9
3.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
642
4909
1.41
11.99
3.4
2.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
91
413
2.25
11.55
1.6
1.2
g/l
0.2
0.2
1.70
83
391
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
36
99
3.67
11.50
1.1
1.1
nmol/l
1.1
0.1
—
7
13
(3020630) Protein [Mass/volume] in Serum or Plasma
197
1175
1.73
11.31
2.3
2.8
g/l
65.4
67.1
2.51
181
1068
(40768797) Stomach Pathology biopsy report
380
2663
1.50
11.18
1.2
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
70
289
2.46
11.01
2.0
1.5
e6/l
5954.0
12058.4
1.50
53
209
(3026493) Urate [Moles/volume] in Serum or Plasma
602
4643
1.39
10.49
2.4
2.2
umol/l
5304.9
4973.8
0.06
523
4060
(3021879) Hepatitis B virus core Ab [Presence] in Serum
223
1407
1.64
10.37
1.3
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
463
3422
1.43
10.30
1.6
1.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
91
435
2.13
10.20
1.6
1.2
g/l
1.2
1.2
1.35
82
410
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
318
2190
1.52
10.13
2.9
2.5
umol/l
7.8
7.3
0.16
277
1872
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
258
1699
1.58
10.06
3.5
4.4
u/l
233.6
247.2
0.72
239
1609
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
182
1098
1.71
10.04
1.6
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
53
200
2.68
10.04
2.3
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2253
21237
1.49
10.00
4.3
3.9
mmol/l
4.8
4.9
2.91
2116
19897
(3023368) Bacteria identified in Blood by Culture
570
4393
1.38
9.91
4.3
3.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1149
9856
1.30
9.48
3.6
3.2
estimate
0.0
0.0
0.80
220
1617
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2163
20282
1.42
9.38
3.8
3.5
mmol/l
1.3
1.2
0.09
2011
18810
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
59
244
2.45
9.30
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2274
21537
1.49
9.21
4.8
4.2
mmol/l
2.9
2.9
0.86
2113
20044
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
392
2877
1.43
8.98
3.0
2.4
e6/l
4.1
3.7
0.27
217
1451
(3024980) IgG subclass 4 [Mass/volume] in Serum
59
249
2.40
8.92
1.5
1.6
g/l
0.7
0.7
0.10
45
190
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2234
21113
1.45
8.88
4.3
3.8
mmol/l
1.5
1.5
2.73
2091
19684
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
372
2720
1.43
8.69
1.8
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1147
9914
1.28
8.64
5.1
4.3
estimate
0.0
0.0
0.80
230
1641
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
89
450
2.01
8.64
2.3
2.2
mg/l
10.0
12.1
1.32
82
420
(3009261) Glucose [Presence] in Urine by Test strip
1156
10003
1.28
8.63
3.7
3.2
estimate
0.0
0.0
1.32
223
1634
(3023520) Reticulocytes [#/volume] in Blood
182
1144
1.64
8.61
2.2
2.2
e9/l
73.6
71.1
0.33
129
856
(3030313) Adrenal Ab [Titer] in Serum
13
8
16.33
8.55
1.1
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
655
5266
1.33
8.46
1.7
1.6
mmol/l
1.3
1.4
0.71
552
4514
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
262
1800
1.51
8.42
7.0
6.7
kpa
5.1
5.1
0.10
251
1721
(3027801) Oxygen [Partial pressure] in Arterial blood
262
1800
1.51
8.42
7.0
6.7
kpa
12.0
13.2
3.10
253
1720
(3007566) Smooth muscle Ab [Titer] in Serum
85
427
2.02
8.41
1.2
1.2
titre
72.0
133.1
—
5
39
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
42
155
2.74
8.35
1.2
1.1
u/l
90.1
61.9
0.61
31
98
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
114
635
1.83
8.31
1.1
1.1
u/ml
3.2
3.4
—
10
83
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
39
139
2.83
8.28
1.6
1.4
%
47.5
62.7
1.41
29
87
(3003396) Base excess in Arterial blood by calculation
261
1801
1.50
8.21
6.9
6.8
mmol/l
1.0
1.0
0.06
200
1404
(3002032) Base excess in Venous blood by calculation
210
1383
1.56
8.19
3.1
3.0
mmol/l
2.0
1.9
0.11
152
1145
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
70
334
2.13
7.95
1.6
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
208
1386
1.54
7.70
3.1
3.0
kpa
5.8
5.8
0.09
195
1349
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
401
3042
1.38
7.51
2.9
2.3
e6/l
1.4
1.3
0.06
223
1601
(3027456) Digoxin [Moles/volume] in Serum or Plasma
60
276
2.20
7.49
4.1
3.2
nmol/l
0.8
0.8
0.04
51
222
(3042936) Bacteria identified in Isolate by Culture
336
2477
1.41
7.45
2.1
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
151
944
1.64
7.33
2.4
2.5
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
226
1551
1.50
7.30
7.3
7.3
%
95.1
96.1
1.41
215
1491
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
150
946
1.62
7.04
6.2
6.4
mmol/l
25.1
24.8
0.56
150
940
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
102
579
1.79
7.04
1.8
1.5
g/l
1.5
1.5
0.25
84
498
(46235355) HIV 1 and 2 tests - Meaningful Use set
526
4197
1.32
7.01
1.8
1.9
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
32
114
2.83
6.84
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
32
114
2.83
6.84
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
32
114
2.83
6.84
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
32
115
2.81
6.74
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
32
115
2.81
6.74
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
32
115
2.81
6.74
1.1
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
291
2130
1.41
6.71
2.0
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
134
840
1.63
6.47
8.1
8.7
mmol/l
24.3
24.3
0.01
125
799
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
118
716
1.68
6.46
2.4
2.1
u/l
40.9
40.1
0.14
108
645
(3011985) Renin [Units/volume] in Plasma
49
222
2.23
6.39
2.6
1.3
mu/l
58.6
39.4
0.72
43
203
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
232
1650
1.45
6.27
2.2
2.0
g/l
0.2
0.2
0.64
217
1557
(3009542) Hematocrit [Volume Fraction] of Blood
2135
20269
1.32
6.22
19.1
11.7
%
40.0
39.6
1.28
1661
15640
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
63
319
2.00
6.19
1.3
1.3
u/ml
188.9
105.8
0.53
16
73
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
253
1833
1.42
6.19
2.9
2.1
u/l
39.8
35.8
0.25
215
1563
(3014111) Lactate [Moles/volume] in Serum or Plasma
202
1409
1.47
6.05
6.5
6.3
mmol/l
1.4
1.3
0.23
192
1363
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
12
23
5.24
6.01
1.7
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
88
504
1.77
5.94
2.0
2.3
ug/l
291.1
1038.1
1.05
79
470
(3000570) Elastase.pancreatic [Mass/mass] in Stool
88
504
1.77
5.94
1.4
1.4
ug/g
291.7
305.6
0.27
53
267
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
66
345
1.94
5.94
1.3
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
652
5454
1.26
5.90
3.7
2.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
146
957
1.56
5.87
2.8
3.3
kpa
5.3
5.2
0.63
138
896
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
115
713
1.64
5.83
1.9
1.9
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
32
125
2.58
5.79
1.3
1.4
umol/l
11.2
11.5
0.06
32
118
(3048929) Epstein Barr virus Ab [Presence] in Serum
97
577
1.71
5.75
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
144
948
1.55
5.69
2.7
3.3
ph
7.4
7.4
0.63
20
122
(3032773) Endomysium IgG Ab [Titer] in Serum
39
169
2.33
5.68
1.0
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
208
1481
1.44
5.61
7.9
7.6
g/l
122.6
121.2
0.48
197
1423
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
472
3819
1.29
5.57
1.7
1.5
pmol/l
46323959.7
54145109.4
0.10
408
3221
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
145
961
1.54
5.56
1.6
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
16
42
3.83
5.53
1.1
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
709
6031
1.24
5.48
3.0
2.8
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
29
112
2.61
5.39
1.2
1.1
titre
101.4
80.0
—
7
9
(3037121) Protein [Mass/volume] in Urine
91
545
1.69
5.29
3.0
3.2
g/l
0.2
0.2
0.16
41
193
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
128
837
1.56
5.23
7.8
9.3
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
5
0
+∞
5.21
1.6
0.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
525
1.70
5.19
1.9
2.6
g/l
3.0
3.0
0.10
74
418
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
51
256
2.01
5.19
6.8
4.9
iu/ml
272.6
296.5
—
8
32
(3015736) pH of Urine
868
7578
1.22
5.18
3.2
3.0
—
6.2
—
0
5
(40761536) Microorganisms panel - Urine sediment
217
1580
1.41
5.18
4.0
3.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
138
920
1.53
5.18
2.7
3.2
mmol/l
2.4
1.8
0.78
97
694
(3020779) Urea [Moles/volume] in Serum or Plasma
180
1267
1.45
5.17
7.4
6.4
mmol/l
9.1
8.5
0.57
171
1211
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
6
13.37
5.08
10.4
23.5
mmol/l
5.1
4.5
—
8
6
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
77
447
1.74
5.02
2.1
2.4
g/l
38.3
38.5
0.16
71
389
(3044941) Cell count panel - Synovial fluid
44
212
2.09
5.00
2.0
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
305
2361
1.33
4.96
4.5
4.1
%
32.3
32.6
0.20
229
1586
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
543
4530
1.25
4.93
1.7
1.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
25
94
2.68
4.91
1.6
1.5
u/l
7.0
5.9
0.16
13
42
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
26
100
2.62
4.89
1.4
1.3
%
42.3
31.7
0.54
16
57
(3008898) HLA-B27 [Presence]
114
738
1.57
4.89
1.1
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
12
28
4.30
4.82
4.0
4.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
553
1.65
4.78
2.2
2.5
g/l
7.5
7.3
0.53
74
430
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
553
1.65
4.78
2.2
2.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
34
151
2.27
4.73
1.3
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
509
1.67
4.71
2.3
2.6
g/l
9.6
9.9
0.36
76
443
(4062490)
36
165
2.20
4.65
1.4
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
71
414
1.74
4.59
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
184
1331
1.41
4.58
3.3
2.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
80
483
1.68
4.56
2.2
2.6
g/l
0.4
0.9
0.54
73
431
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
89
553
1.63
4.55
2.2
2.5
g/l
3.9
3.7
0.32
74
403
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
140
966
1.48
4.49
2.6
2.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
26
105
2.49
4.46
1.5
1.3
e6/l
34056.1
175786.8
0.90
17
77
(3028192) IgG subclass 2 [Mass/volume] in Serum
35
162
2.18
4.43
1.3
1.4
g/l
2.8
2.9
0.15
23
118
(3027135) IgG subclass 1 [Mass/volume] in Serum
35
162
2.18
4.43
1.3
1.4
g/l
6.2
6.4
0.20
23
117
(3024139) IgG subclass 3 [Mass/volume] in Serum
35
162
2.18
4.43
1.3
1.4
g/l
0.3
0.4
1.50
23
117
(3004616) Nuclear Ab [Presence] in Serum
38
182
2.10
4.42
1.2
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
101
652
1.57
4.42
1.9
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
177
1283
1.41
4.37
8.5
7.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
15
45
3.35
4.32
3.7
2.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
189
1391
1.39
4.27
2.3
2.3
au/ml
23.9
21.4
—
8
105
(3035320) C reactive protein [Mass/volume] in Body fluid
31
139
2.25
4.25
2.1
2.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
60
342
1.77
4.22
1.8
2.2
g/l
133.2
129.8
0.50
39
249
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
183
1343
1.39
4.21
2.2
2.2
ug/l
10.2
6.1
0.62
146
1182
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
242
1860
1.33
4.15
1.7
1.6
—
—
—
0
0
(3000492) Spirometry study
262
2038
1.32
4.14
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
41
210
1.97
4.02
1.1
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
27
117
2.32
4.01
1.3
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
53
296
1.81
4.00
2.5
2.3
ug/min
43.2
99.1
0.69
32
172
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
88
564
1.58
4.00
1.2
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
58
333
1.76
4.00
2.8
2.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
41
211
1.96
3.97
1.1
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
711
6219
1.20
3.97
1.5
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
151
1084
1.42
3.96
2.3
2.1
u/l
5267.8
5984.1
0.11
66
435
(3005988) Vibrio sp identified in Specimen by Organism specific culture
41
212
1.95
3.92
1.1
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
202
1525
1.35
3.92
1.5
1.3
iu/l
25.7
31.1
1.88
174
1338
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
18
65
2.78
3.85
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
346
2821
1.26
3.80
1.2
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
171
1265
1.38
3.78
1.2
1.3
au/ml
47.4
40.0
—
6
62
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
27
121
2.24
3.73
1.2
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
20
78
2.58
3.71
1.2
1.1
u/l
62.4
80.7
1.11
13
61
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
20
78
2.58
3.71
1.2
1.1
u/l
10.1
25.6
2.16
12
60
(3028433) Virus identified in Specimen by Culture
15
50
3.01
3.68
1.0
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
41
217
1.90
3.68
1.5
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
14
45
3.12
3.65
1.4
1.5
ug/l
0.5
0.4
—
7
27
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
23
97
2.38
3.65
1.4
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
102
691
1.50
3.64
2.7
3.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
36
183
1.98
3.63
1.8
1.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
53
307
1.74
3.58
1.2
1.2
u/ml
2.8
2.9
0.04
23
80
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
60
360
1.68
3.57
1.1
1.0
u/ml
2.8
2.1
0.29
22
187
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
64
391
1.65
3.56
1.6
1.5
e6/l
48.0
33.8
0.22
49
302
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
238
1867
1.30
3.56
1.8
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
41
220
1.88
3.54
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
40
213
1.89
3.54
1.1
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
64
392
1.65
3.53
1.6
1.5
e6/l
915.8
2187.2
0.73
52
320
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
26
3.86
3.52
1.7
1.2
ug/l
10.1
9.3
—
10
26
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
28
131
2.15
3.51
1.3
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
23
99
2.34
3.50
1.1
1.1
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
6
6
10.02
3.49
2.2
1.3
nmol/l
629.8
2877.5
—
6
6
(1616796) Gas panel - Central venous blood
54
317
1.72
3.49
3.2
3.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
30
145
2.08
3.47
3.1
3.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
40
217
1.86
3.36
1.1
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
23
101
2.29
3.36
1.2
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
277
2233
1.27
3.36
1.5
1.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
55
331
1.68
3.27
3.7
3.4
kpa
8.8
8.8
0.09
55
325
(3006462) Nitrate [Presence] in Urine
22
96
2.30
3.26
3.1
2.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
7
8.59
3.26
2.5
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
90
610
1.49
3.24
2.6
3.4
mmol/l
25.3
24.9
0.41
82
564
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
39
213
1.84
3.22
1.2
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
226
1786
1.29
3.21
3.2
3.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
61
379
1.62
3.21
1.1
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
24
110
2.19
3.19
1.1
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
253
2031
1.27
3.18
7.2
6.4
mmol/l
104.7
104.6
0.15
248
1996
(3004809) Band form neutrophils/100 leukocytes in Blood
39
214
1.84
3.18
2.6
3.3
%
1.0
1.6
0.77
29
173
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
136
1002
1.38
3.13
1.6
1.5
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
39
216
1.82
3.10
1.4
1.3
pmol/l
380.4
302.9
0.47
32
171
(3015235) Bicarbonate [Moles/volume] in Capillary blood
59
368
1.62
3.07
2.9
2.7
mmol/l
25.6
24.8
0.47
53
327
(3045414) Leukocytes [Presence] in Urine
121
878
1.40
3.05
1.7
1.8
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
54
330
1.65
3.05
3.7
3.4
kpa
4.9
5.0
0.21
54
324
(3012501) Base excess in Blood by calculation
54
330
1.65
3.05
3.7
3.4
mmol/l
2.6
2.4
0.26
42
208
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
41
232
1.78
3.04
1.1
1.3
nmol/l
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
17
68
2.51
3.04
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
58
363
1.61
2.99
1.7
1.5
—
—
—
0
0
(4211845)
23
107
2.16
2.96
3.0
2.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
55
341
1.63
2.95
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
67
436
1.55
2.94
1.8
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
116
843
1.39
2.92
2.6
2.3
e6/l
0.2
0.3
0.10
111
809
(3017354) Segmented neutrophils/100 leukocytes in Blood
26
128
2.04
2.91
2.2
3.0
%
64.4
59.3
0.66
16
92
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
49
296
1.67
2.91
1.3
1.2
u/ml
2.8
5.2
1.09
23
111
(3024354) Oxygen [Partial pressure] in Venous blood
153
1163
1.34
2.90
2.8
2.6
kpa
4.8
4.6
0.62
143
1130
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
31
164
1.90
2.85
1.1
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
97
686
1.43
2.85
1.7
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
38
215
1.78
2.84
1.2
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
19
83
2.30
2.84
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
70
466
1.52
2.79
1.8
2.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
52
323
1.62
2.78
2.2
2.2
umol/l
4.3
4.7
0.31
35
231
(3010421) pH of Blood
63
410
1.55
2.78
3.3
3.3
ph
7.4
7.4
1.23
54
324
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
165
1277
1.31
2.77
1.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
51
316
1.63
2.76
1.3
1.2
u/ml
322.0
242.9
1.17
32
203
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
80
550
1.47
2.74
2.2
1.9
ug/l
0.5
1.6
1.89
66
491
(3019060) Gas panel - Arterial blood
133
1000
1.35
2.73
4.7
4.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
16
66
2.43
2.71
1.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
16
66
2.43
2.71
1.3
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
66
437
1.52
2.71
1.5
1.3
mg/l
472.8
504.1
0.29
61
415
(3020717) Zinc [Moles/volume] in Serum or Plasma
21
98
2.15
2.70
1.4
1.3
umol/l
39.9
26.6
0.77
21
92
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
11
37
2.98
2.69
1.2
1.3
ng/l
70.7
79.7
0.17
11
37
(3018677) aPTT in Platelet poor plasma by Coagulation assay
313
2625
1.22
2.68
2.5
2.1
s
30.4
29.4
1.62
299
2545
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
19
86
2.22
2.63
1.2
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
75
514
1.47
2.62
6.2
5.4
mmol/l
1.2
1.2
0.04
69
445
(3003181) Sodium [Moles/volume] in Urine
44
267
1.66
2.60
1.3
1.3
mmol/l
70.8
61.7
0.62
36
211
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
87
2.19
2.57
1.2
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
16
68
2.36
2.55
1.2
1.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
131
994
1.33
2.55
8.7
8.4
%
1.4
1.4
0.10
131
989
(3029937) Albumin [Presence] in Urine by Test strip
574
5104
1.16
2.51
4.0
3.4
estimate
0.0
0.0
1.74
224
1620
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
47
293
1.62
2.51
1.6
1.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
20
95
2.11
2.48
1.1
1.0
u/l
1.2
1.0
—
8
40
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
26
3.47
2.48
1.2
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
19
89
2.14
2.44
1.9
1.3
u/l
4.9
5.6
0.37
14
73
(40768443) Skin Pathology biopsy report
104
768
1.37
2.43
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
91
658
1.40
2.41
1.4
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
23
117
1.97
2.40
1.3
1.1
mg/l
42.1
36.0
0.31
18
102
(3014765) Yersinia sp identified in Stool by Organism specific culture
81
575
1.42
2.38
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1607
15319
1.13
2.37
3.5
3.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
64
436
1.48
2.34
1.8
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
68
470
1.46
2.31
2.9
3.4
u/ml
0.3
0.4
1.15
32
272
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
58
388
1.51
2.31
1.2
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
56
372
1.52
2.31
1.5
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
517
4590
1.16
2.30
3.1
3.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
51
332
1.55
2.30
2.6
2.6
kpa
8.2
8.3
0.15
46
311
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
33
192
1.73
2.30
1.1
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
16
72
2.23
2.27
1.1
1.1
iu/ml
166.0
169.4
0.03
16
72
(42529406) Shigella sp [Presence] in Stool by Culture
81
582
1.40
2.24
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
80
574
1.41
2.24
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
839
7713
1.13
2.22
3.9
3.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
570
5110
1.15
2.22
1.4
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
129
999
1.31
2.22
9.1
8.5
%
94.1
94.2
0.12
129
994
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
14
60
2.34
2.21
1.0
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
124
957
1.31
2.19
6.5
6.5
mmol/l
24.6
24.6
0.03
114
878
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
128
1635
0.77
2.18
1.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
67
468
1.44
2.18
2.4
2.8
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
28
158
1.78
2.17
1.3
1.3
e6/l
1016.7
1974.0
1.78
22
114
(3021387) Prolactin [Units/volume] in Serum or Plasma
119
916
1.31
2.14
1.6
1.6
mu/l
265.5
305.6
1.39
103
829
(21494755) Public health laboratory ask at order entry panel
217
2603
0.82
2.14
1.2
1.3
—
—
—
0
0
(4035726)
220
1826
1.22
2.13
1.5
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
84
616
1.38
2.09
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
38
237
1.61
2.07
1.2
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
31
2.91
2.07
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
31
2.91
2.07
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
31
2.91
2.07
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
31
2.91
2.07
1.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
42
269
1.57
2.06
2.5
2.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
28
161
1.75
2.06
1.4
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
185
1514
1.24
2.05
1.2
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
15
69
2.18
2.04
1.5
2.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
27
154
1.76
2.04
1.3
1.1
u/ml
0.1
0.9
0.65
18
68
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
44
2.51
2.01
1.7
1.7
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
14
63
2.23
2.01
3.1
7.4
mg/l
92.4
73.7
—
9
35
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
21
111
1.90
2.00
1.1
1.1
mg/l
237.8
242.3
0.04
16
100
(3036603) Volume of Urine
24
133
1.81
1.99
1.5
1.4
ml
1998.7
1950.4
—
6
20
(3034860) Kappa light chains.free [Mass/volume] in Serum
62
437
1.43
1.95
3.4
3.5
mg/l
31.5
64.7
1.20
46
360
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
64
2.19
1.94
1.1
1.0
miu/ml
1432.6
1377.5
0.06
14
64
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
11
4.55
1.94
1.0
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
11
4.55
1.94
4.2
2.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
124
975
1.29
1.94
3.2
2.6
g/l
132.4
129.8
0.64
117
952
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
51
347
1.48
1.92
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
24
135
1.79
1.91
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
46
307
1.51
1.90
1.9
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
45
299
1.51
1.90
1.5
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
92
1.96
1.90
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
143
1.76
1.89
1.3
1.3
e6/l
19369.8
70417.6
0.78
19
79
(4268621)
34
212
1.61
1.88
2.1
2.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
14
65
2.16
1.88
2.6
1.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
22
3.19
1.88
1.0
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
52
2.31
1.87
1.8
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
45
301
1.50
1.85
1.2
1.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
17
3.54
1.83
1.3
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
21
115
1.83
1.82
1.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
124
984
1.27
1.82
1.4
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
48
327
1.48
1.81
2.2
2.3
%
16.7
16.3
0.21
24
162
(4027681)
17
87
1.96
1.79
1.3
1.2
—
—
—
0
0
(4094501)
68
497
1.38
1.77
1.1
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
61
439
1.40
1.74
3.4
3.5
mg/l
25.9
49.0
0.97
45
360
(3051651) Icteric interference index of Serum or Plasma
21
117
1.80
1.74
3.2
3.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
78
586
1.34
1.72
1.4
1.3
u/l
12.8
12.4
0.09
67
488
(3011648) Oxygen content in Venous blood
23
133
1.74
1.70
1.7
1.9
%
12.4
10.7
1.00
23
133
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
31
195
1.60
1.68
1.7
1.6
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
10
42
2.39
1.67
47.5
33.8
ug/l
7.1
8.1
—
10
36
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
62
451
1.38
1.67
1.4
1.3
u/l
29.9
26.8
0.27
48
377
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
28
172
1.63
1.67
2.1
1.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
52
367
1.43
1.66
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
52
367
1.43
1.66
1.2
1.2
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
19
3.16
1.66
1.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
31
2.59
1.66
1.1
1.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
32
204
1.58
1.65
1.9
1.7
%
89.0
90.1
0.27
32
199
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
16
83
1.93
1.64
2.1
2.4
%
46.0
40.5
—
7
29
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
15
76
1.98
1.64
1.5
2.9
umol/l
195.9
189.3
—
8
37
(3037756) Immunofixation for Serum or Plasma
41
278
1.48
1.61
2.1
1.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
84
645
1.31
1.61
2.6
3.4
u/ml
210.3
2429.4
0.82
66
558
(3019977) pH of Arterial blood
15
77
1.95
1.59
1.6
4.2
ph
7.4
7.4
—
6
26
(3044927) Protein electrophoresis panel - Urine
21
121
1.74
1.58
1.7
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
7
26
2.70
1.58
1.3
1.1
mg/g
6.5
6.3
—
7
26
(3023183) Ammonium ion [Moles/volume] in Plasma
46
321
1.44
1.58
2.1
2.9
umol/l
31.9
34.6
0.46
38
277
(3028271) Lactate [Moles/volume] in Capillary blood
37
247
1.51
1.57
2.3
1.7
mmol/l
1.6
1.6
0.37
37
242
(4034850)
51
705
0.72
1.57
15.0
6.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
50
2.21
1.57
1.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
43
297
1.46
1.56
1.1
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
80
614
1.31
1.55
2.4
2.0
%
95.2
93.6
0.27
75
556
(4146454)
25
153
1.64
1.53
3.4
2.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
201
2341
0.85
1.49
1.6
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
290
2554
1.15
1.48
1.5
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
9
37
2.44
1.48
1.9
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
94
1.81
1.47
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
19
109
1.75
1.46
1.0
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
26
163
1.60
1.46
1.1
1.1
nmol/l
353.8
385.0
0.33
21
149
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
16
3.13
1.44
1.0
1.3
u/l
55.6
6.8
—
5
16
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
22
2.73
1.43
1.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
66
1.97
1.43
2.5
2.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
106
855
1.25
1.42
1.5
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
44
312
1.42
1.41
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
117
955
1.24
1.41
3.2
3.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
287
2537
1.15
1.40
1.6
1.7
—
—
—
0
0
(44790048)
29
189
1.54
1.40
1.7
1.4
—
—
—
0
0
(44790047)
29
189
1.54
1.40
1.7
1.4
—
—
—
0
0
(44790049)
29
189
1.54
1.40
1.7
1.4
—
—
—
0
0
(44806118)
29
189
1.54
1.40
1.7
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
21
126
1.67
1.40
1.1
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
46
330
1.40
1.39
1.1
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
19
111
1.72
1.39
1.0
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
286
2530
1.15
1.38
4.3
4.6
ug/l
2.3
2.4
0.11
249
2271
(3016018) Differential panel - Cerebral spinal fluid
29
190
1.53
1.37
2.1
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
41
289
1.43
1.37
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
21
127
1.66
1.36
1.1
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
79
618
1.29
1.36
6.1
4.7
%
0.8
0.9
0.58
74
569
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
52
383
1.37
1.35
1.5
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
11
54
2.04
1.32
1.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
54
2.04
1.32
1.2
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
61
1.97
1.32
1.8
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
61
1.97
1.32
1.8
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
174
1487
1.18
1.32
2.6
2.9
ug/l
0.8
0.7
0.40
100
942
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
108
882
1.23
1.31
1.4
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
222
1937
1.16
1.31
1.8
1.8
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
6
24
2.50
1.30
1.3
1.4
nmol/l
5.5
1564712.5
—
6
17
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
65
838
0.77
1.29
1.8
2.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
23
145
1.59
1.29
2.2
1.6
mmol/l
6.8
6.3
0.33
18
102
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
43
311
1.39
1.26
1.5
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
91
733
1.25
1.26
2.9
2.7
mmol/l
25.0
25.5
0.61
83
710
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
16
92
1.74
1.25
1.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
16
92
1.74
1.25
1.1
1.3
nmol/l
116.9
136.6
0.95
16
92
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
36
2.23
1.24
8.5
6.2
—
—
—
0
0
(4010399)
161
1376
1.18
1.24
1.5
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
27
179
1.51
1.23
3.5
3.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
31
213
1.46
1.20
1.9
1.9
mg/l
29.7
23.5
—
9
60
(3004451) EKG impression Narrative
13
71
1.84
1.19
1.2
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
23
149
1.55
1.17
1.2
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
110
1.64
1.15
1.8
1.9
%
10.9
12.8
—
7
54
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
24
158
1.52
1.14
1.8
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
21
134
1.57
1.14
1.0
1.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
21
134
1.57
1.14
2.6
2.2
e9/l
1.1
1.4
1.11
15
89
(3015183) Erythrocyte sedimentation rate
22
142
1.55
1.14
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
43
318
1.36
1.13
3.9
3.7
—
—
—
0
0
(3036489) Thrombin time
90
735
1.23
1.13
2.3
1.8
s
22.0
21.2
0.31
84
622
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
8
40
2.00
1.12
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
31
2.26
1.10
1.0
1.8
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
21
2.38
1.09
1.2
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
21
2.38
1.09
3.8
3.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
171
1487
1.16
1.09
1.4
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
162
1403
1.17
1.09
1.4
1.2
u/ml
180.1
174.0
0.05
153
1293
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
99
823
1.21
1.06
1.3
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
137
1174
1.18
1.05
1.3
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
33
2.12
1.05
6.6
6.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
99
825
1.21
1.04
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
99
825
1.21
1.04
1.3
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1943
19034
1.09
1.03
22.3
13.6
g/l
331.6
331.9
0.96
1932
18891
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
99
826
1.21
1.03
1.3
1.4
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
15
91
1.65
1.00
3.1
3.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
35
2.00
1.00
2.0
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
138
1192
1.17
0.98
1.2
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
36
1.95
0.97
1.3
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
157
1.47
0.96
1.7
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
25
174
1.44
0.95
1.7
1.5
mosm/kgh2o
277.0
279.3
0.15
17
133
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
109
1.56
0.93
1.7
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
53
418
1.27
0.93
1.9
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
55
1.82
0.92
1.7
2.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
28
2.15
0.91
7.5
6.5
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
13
78
1.67
0.91
1.2
1.5
umol/l
1.7
2.0
1.13
13
72
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
222
1994
1.12
0.91
3.3
4.0
ug/l
10.4
22.4
1.11
170
1565
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
27
193
1.40
0.90
1.4
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
74
610
1.22
0.89
1.5
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
21
143
1.47
0.89
1.2
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
171
1513
1.14
0.89
2.9
2.3
ml/min/173m2
66.0
71.2
0.77
64
589
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
29
2.07
0.89
1.0
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
26
185
1.41
0.89
1.4
1.4
mmol/l
19.1
11.3
—
7
27
(3036071) Salmonella sp Ab [Titer] in Serum
12
71
1.69
0.88
1.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
19
127
1.50
0.88
1.5
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
70
575
1.22
0.88
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
169
1497
1.14
0.87
1.7
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
44
1.82
0.85
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
72
1.67
0.85
1.2
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
8
45
1.78
0.84
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
275
1.31
0.82
1.6
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
32
1.88
0.81
2.2
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
206
1.36
0.81
1.6
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
47
1.70
0.80
1.5
2.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
47
1.70
0.80
1.3
1.3
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.2
—
0.0
—
0
16
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
16
106
1.51
0.79
14.2
13.2
mmol/l
0.7
0.6
0.65
16
97
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
16
106
1.51
0.79
1.4
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
46
366
1.26
0.78
1.1
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
224
2035
1.11
0.78
3.9
4.1
%
24.0
20.8
1.70
87
923
(3017446) Testosterone [Moles/volume] in Serum or Plasma
89
759
1.18
0.78
1.9
2.0
nmol/l
10.5
10.9
0.14
76
677
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
178
1597
1.12
0.77
2.8
3.5
u/ml
77.8
53.4
0.45
171
1541
(1761482) Bacteria [#/volume] in Urine by Culture
55
450
1.23
0.75
4.5
4.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
24
2.09
0.74
3.6
2.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
24
2.09
0.74
1.2
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
57
469
1.22
0.74
1.6
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
38
1.84
0.73
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
135
0.59
0.73
1.0
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
25
2.00
0.72
1.4
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
31
237
1.31
0.72
1.5
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
11
68
1.62
0.71
1.2
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
35
273
1.29
0.71
1.1
1.1
iu/ml
69.7
27.5
—
5
59
(3024471) HLA-A [Type]
7
40
1.75
0.71
1.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
61
1.64
0.68
1.6
3.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
37
293
1.27
0.68
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
19
136
1.40
0.66
1.2
1.1
ratio
1.0
1.0
—
8
51
(3002523) Influenza virus A Ag [Presence] in Specimen
45
366
1.23
0.66
1.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
10
62
1.62
0.65
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
97
849
1.15
0.64
1.2
1.3
miu/ml
214.4
225.2
0.12
56
443
(4306422)
41
332
1.24
0.63
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
21
155
1.36
0.63
1.6
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
25
191
1.31
0.61
2.0
2.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
13
88
1.48
0.60
3.0
2.3
e6/l
993.2
671.1
—
5
31
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
28
218
1.29
0.60
1.8
1.7
—
1485.7
—
0
7
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
72
1.53
0.59
1.4
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
72
1.53
0.59
1.4
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
106
1.42
0.57
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
25
193
1.30
0.57
1.1
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
47
392
1.20
0.57
1.4
1.4
ug/l
2.5
3.9
1.21
41
352
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
14
98
1.43
0.56
3.1
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
9
61
1.48
0.53
1.1
3.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
39
1.54
0.53
1.5
4.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
39
1.54
0.53
1.5
4.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(44813793)
20
153
1.31
0.50
1.3
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
41
1.46
0.50
1.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
54
627
0.86
0.50
1.5
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
80
708
1.13
0.49
1.4
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
84
1.43
0.49
1.2
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
84
1.43
0.49
1.2
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
84
1.43
0.49
1.2
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
84
1.43
0.49
1.3
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
62
710
0.87
0.48
1.3
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
290
2735
1.07
0.48
1.9
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
284
2677
1.07
0.48
2.1
1.9
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
19
146
1.30
0.47
2.1
2.7
mg/l
27.1
23.8
—
10
98
(40768441) Liver Pathology biopsy report
16
120
1.34
0.46
1.6
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
49
1.43
0.46
1.1
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
32
264
1.21
0.45
1.7
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
32
384
0.83
0.44
1.0
1.1
u/ml
0.7
3.6
—
9
137
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
36
302
1.19
0.44
1.3
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
16
121
1.32
0.44
1.3
1.5
—
63.6
—
0
13
(3019150) Specific gravity of Urine by Refractometry
446
4279
1.05
0.42
4.2
3.5
kg/l
1.0
1.0
0.10
86
638
(1761868) Lipid panel - Serum or Plasma
847
8245
1.04
0.42
2.6
2.4
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
56
1.43
0.42
1.3
1.9
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
52
453
1.15
0.42
1.8
1.4
nmol/l
0.4
0.4
0.01
40
367
(3038177) Helicobacter pylori Ab [Presence] in Serum
49
425
1.16
0.42
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
23
185
1.25
0.41
1.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
33
1.52
0.41
5.2
3.1
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.1
—
0
7
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
10.7
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.1
—
0
10
(3011288) Drugs identified in Urine by Screen method
52
593
0.87
0.40
1.8
2.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
186
1.24
0.40
1.5
1.6
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
16
205
0.78
0.40
1.2
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
42
362
1.16
0.39
1.1
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
46
527
0.87
0.39
1.5
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
63
706
0.89
0.38
1.4
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
159
0.75
0.38
2.9
2.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
76
686
1.11
0.37
1.4
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
48
421
1.14
0.37
3.6
3.1
mg/l
20.2
26.4
0.60
23
247
(3047189) Immunofixation for 24 hour Urine
5
76
0.66
0.35
3.8
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
76
689
1.11
0.35
1.4
1.4
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
1.0
1.2
umol/l
17.2
17.2
—
6
37
(3051593) INR in Capillary blood by Coagulation assay
10
73
1.37
0.34
1.1
10.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
163
1.23
0.34
1.6
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
20
163
1.23
0.34
2.5
3.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
45
1.33
0.33
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
14
109
1.29
0.33
1.3
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
144
0.76
0.33
3.1
2.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
46
1.31
0.33
1.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
137
1.24
0.32
1.4
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
137
1.24
0.32
1.4
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
137
1.24
0.32
1.4
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
83
1.33
0.32
1.5
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
52
1.35
0.31
2.0
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
31
358
0.86
0.31
1.1
1.1
u/ml
0.4
4.2
4.12
13
130
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
54
1.30
0.30
1.1
1.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
15
120
1.25
0.30
1.1
1.5
nmol/l
1.7
1.6
—
10
112
(3000764) Benzodiazepines [Presence] in Urine
92
851
1.08
0.30
1.4
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
84
774
1.09
0.29
1.5
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
7
56
1.25
0.29
2.4
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
91
843
1.08
0.29
1.4
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
92
854
1.08
0.28
1.4
1.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
62
1.29
0.28
1.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
117
0.77
0.27
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
65
1.23
0.27
3.9
3.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
18
150
1.20
0.26
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
24
206
1.17
0.26
1.1
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
28
320
0.87
0.25
1.1
1.1
u/ml
0.2
0.4
—
7
62
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
313
3025
1.04
0.25
2.3
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
92
859
1.07
0.25
1.4
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
38
340
1.12
0.24
1.1
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
87
1.27
0.24
1.4
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
119
1125
1.06
0.23
1.4
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
23
199
1.16
0.23
2.0
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
25
219
1.14
0.22
1.2
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
12
146
0.82
0.22
1.1
1.3
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033942) Copper [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
0.3
—
0
5
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
14.3
—
0
10
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
7
(3017315) Amylase [Enzymatic activity/volume] in Urine
8
104
0.77
0.21
1.3
1.2
u/l
218.0
343.9
—
8
94
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
8
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4133840)
6
48
1.25
0.20
1.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
21
239
0.88
0.19
1.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
51
1.18
0.19
1.0
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
53
1.13
0.18
2.8
3.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
17
147
1.16
0.18
1.2
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
176
1.14
0.17
1.5
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
29
262
1.11
0.17
1.4
1.7
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
24
215
1.12
0.16
1.6
1.6
mmol/l
7.6
7.6
0.03
15
122
(1002224) Polysomnography panel
96
915
1.05
0.16
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
236
2294
1.03
0.16
6.7
5.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
36
331
1.09
0.16
1.4
1.4
mmol/l
7.2
7.0
0.12
25
240
(1001926) Buprenorphine [Presence] in Urine by Screen method
69
653
1.06
0.15
1.5
1.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
140
1.14
0.15
1.1
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
9
81
1.11
0.15
1.7
1.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
81
1.11
0.15
1.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
92
961
0.96
0.14
2.0
1.7
mg/l
2.4
3.6
1.05
70
660
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
37
343
1.08
0.14
2.7
1.7
nmol/l
0.9
0.9
0.10
30
299
(3039443) Prostate specific Ag panel - Serum or Plasma
19
170
1.12
0.13
1.5
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
35
376
0.93
0.13
1.6
2.4
—
—
—
0
0
(4198724)
10
85
1.18
0.12
1.2
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
23
211
1.09
0.11
1.1
1.1
—
—
—
0
0
(4024509)
21
192
1.09
0.10
1.7
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
36
339
1.06
0.10
1.1
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
44
1.14
0.10
1.2
1.2
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
5
45
1.11
0.09
1.2
1.2
nmol/l
128.4
83.9
—
5
31
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
252
2479
1.02
0.09
1.5
1.7
%
1.4
1.4
0.02
222
2216
(3033799) Differential panel - Peritoneal fluid
5
61
0.82
0.08
1.0
1.8
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
62
0.81
0.08
1.8
1.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
25
234
1.07
0.08
2.4
2.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
66
1.06
0.08
1.1
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
44
421
1.05
0.07
1.1
1.1
u/ml
0.2
1.9
—
9
93
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
6
71
0.84
0.07
1.2
1.4
—
72.7
—
0
20
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
74
1.08
0.07
1.4
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
74
1.08
0.07
1.4
1.7
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
8
74
1.08
0.07
1.1
1.1
—
3.1
—
0
12
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
74
1.08
0.07
1.5
1.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
16
147
1.09
0.07
1.2
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
84
0.83
0.07
2.4
2.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
13
118
1.10
0.07
1.7
1.8
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
86
1.05
0.07
2.7
2.5
ug/l
20.5
19.2
—
9
78
(3026470) Cobalt [Mass/volume] in Blood
10
89
1.12
0.06
2.6
2.1
ug/l
2.9
3.0
—
10
83
(4281824)
28
295
0.95
0.06
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
15
138
1.09
0.06
1.7
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
105
0.86
0.06
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
18
193
0.93
0.06
3.3
2.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
119
1.09
0.06
3.2
2.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
192
0.94
0.05
1.1
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
45
435
1.04
0.05
1.0
1.1
u/ml
0.4
1.3
1.35
21
164
(3020874) Milk IgE Ab [Units/volume] in Serum
18
169
1.07
0.05
1.0
1.0
u/ml
0.3
1.9
—
7
47
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
170
0.94
0.04
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
50
512
0.98
0.03
1.1
1.1
u/ml
4.7
1.3
0.60
22
184
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
102
1.08
0.03
2.3
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
81
798
1.02
0.03
1.9
1.7
—
—
—
0
0
(3020891) Body temperature
62
630
0.98
0.02
4.3
4.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
53
521
1.02
0.02
3.3
2.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
46
453
1.02
0.01
1.0
1.1
u/ml
2.3
5.7
2.44
25
220
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
13
124
1.05
0.00
1.2
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
10
101
0.99
0.00
1.8
1.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
106
1065
1.00
0.00
1.5
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
98
1.02
0.00
1.2
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
72
718
1.00
0.00
1.3
1.5
pmol/l
217.9
171.4
0.13
72
705
(40761535) Cells panel - Urine sediment
143
1432
1.00
0.00
3.6
2.8
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
18
177
1.02
0.00
1.5
1.3
g/l
0.8
0.9
1.21
18
177
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
80
1.00
0.00
1.5
1.6
—
768403.8
—
0
8
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.3
—
0
6
(4038314)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
75
0.93
0.00
1.6
1.5
—
—
—
0
0
(3022670) pH of Venous cord blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
14.1
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
120.5
—
0
5
(3029396) Erythrocyte agglutination [Presence] in Blood
7
71
0.99
0.00
2.6
3.5
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
5
0.00
0.00
0.0
1.2
—
61.1
—
0
5
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
52
0.96
0.00
1.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
140
1.00
0.00
1.1
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
66
0.91
0.00
1.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
0.8
—
0
5
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
98
0.92
0.00
1.2
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AUTOIMMUNE_HYPERTHYROIDISM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AUTOIMMUNE_HYPERTHYROIDISM | 1.083 [0.97, 1.21] | 0.162 |
| Birth year | 0.998 [0.99, 1.01] | 0.617 |
During the follow-up period (1.1.1998 — 31.12.2019), 1133 out of 10957 females with AUTOIMMUNE_HYPERTHYROIDISM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AUTOIMMUNE_HYPERTHYROIDISM | 1.223 [1.05, 1.42] | 0.008 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 392 out of 2528 males with AUTOIMMUNE_HYPERTHYROIDISM died.
Mortality risk
Mortality risk for people of age
years, who have AUTOIMMUNE_HYPERTHYROIDISM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.117% | 0.217% |
| 5 | 0.744% | 1.299% |
| 10 | 1.652% | 3.238% |
| 15 | 3.454% | 6.115% |
| 20 | 6.064% | 10.044% |
Relationships between endpoints
↥Index endpoint: AUTOIMMUNE_HYPERTHYROIDISM – Autoimmune hyperthyroidism
GWS hits: 12
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data